Octapharma Adds Track & Trace to Werum’s PAS-X

Octapharma has added the PAS-X Track & Trace Serialization Aggregation solution to Werum’s PAS-X at its production site in Vienna. Octapharma employs strict in-process quality control systems to ensure traceability, providing the complete documentation of the origin of all plasma products, their processing and distribution to countries worldwide.
 
PAS-X Track & Trace will initially be operated in the packaging area for the Chinese market. The serialization data provided by the Chinese authorities are loaded and the used data are reported back. PAS-X Track & Trace is interfaced to the existing PAS-X and exchanges order and stock data with the MES. The company plans to install Werum’s PAS-X Track & Trace at further packaging lines for different target countries in the Vienna site.
 
Octapharma develops and produces human proteins from human plasma and human cell-lines for haematology, immunotherapy and critical care therapies, and has five production facilities in Austria, France, Germany, Sweden and Mexico.